3,6-Dichloropyridazine → 6-((6-Chloro-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)difluoromethyl)quinoline

HRID 40383

反応式

HRID 40383 の反応式
[F:1][C:2]([F:17])([C:7]1[CH:8]=[C:9]2[C:14](=[CH:15][CH:16]=1)[N:13]=[CH:12][CH:11]=[CH:10]2)[C:3]([NH:5][NH2:6])=O.[Cl:18][C:19]1[N:20]=[N:21][C:22](Cl)=[CH:23][CH:24]=1>Cl.CO>[Cl:18][C:19]1[CH:24]=[CH:23][C:22]2[N:5]([C:3]([C:2]([F:17])([F:1])[C:7]3[CH:8]=[C:9]4[C:14](=[CH:15][CH:16]=3)[N:13]=[CH:12][CH:11]=[CH:10]4)=[N:20][N:21]=2)[N:6]=1

参加物

5

反応条件

温度
90 °C

実験手順

A suspension of 2,2-difluoro-2-(quinolin-6-yl)acetohydrazide (2000 mg, 8432 μmol) and 3,6-dichloropyridazine (3768 mg, 25295 μmol) in 1.25 M HCl in MeOH (20 mL) was heated to 90° C. with microwaves for 50 min. The solvents were then removed under reduced pressure and residue partitioned between 9:1 CHCl3/IPA (60 mL) and 1 M NaOH (20 mL). The organic phase then dried over MgSO4, concentrated, then purified on silica (120 g) eluting with 1>2.5% of 2 M NH3 in MeOH/DCM to provide product isolated as a dark tan solid. MS (ESI pos. ion) m/z: 332 (MH+). Calc'd exact mass for C15H8ClF2N5: 331.

後処理

  1. customThe solvents were then removed under reduced pressure and residue
  2. custompartitioned between 9:1 CHCl3/IPA (60 mL) and 1 M NaOH (20 mL)
  3. dry with materialThe organic phase then dried over MgSO4
  4. concentrationconcentrated
  5. custompurified on silica (120 g)
  6. washeluting with 1>2.5% of 2 M NH3 in MeOH/DCM
  7. customto provide product
  8. customisolated as a dark tan solid

出典と根拠

ORDレコード
ord-c84f7e07d9cb45bc9796ee6947f588a3
出典データセット
uspto-grants-2013_09
特許番号
US08524900B2

関連ノート

読み込み中…